Not just humans benefit from animal biotechnologyOctober 25, 2007Laboratory animals are the source of major discoveries and breakthroughs in biology, not just in tackling disease but also unravelling fundamental molecular processes. Delegates at a recent research conference organised by the European Science Foundation (ESF) and Wellcome Trust heard how technology capable of analysing animal genes across the whole genome is yielding many benefits for agriculture and human society. In breeding both domestic and farm animals for example, it is now possible to select individuals with a wide spectrum of desirable traits in a single generation. In the past selective breeding of animals has been confined to traits that are obvious or easy to measure, and it has been difficult to produce individuals with a broad combination of desirable qualities, according to Helen Sang, chair of the recent ESF/Wellcome conference on Animal Biotechnology. "There is the potential to increase the effectiveness of genetic selection, even for traits that are difficult or take a long time to measure," said Sang from the Roslin Institute Department of Gene Function & Development Edinburgh United Kingdom. The key point here is that it is now possible to identify individual animals for breeding, and select offspring, with the best overall combination of gene variants (alleles) rather than focusing on just one or two traits. Sang is also
This ability to measure whole genomes is also helping unravel the genetic components of many multi-gene diseases in both humans and animals. "It is impressive how quickly specific mutations can be mapped in farm animal species and the dog, now that genome sequences are available and SNP maps," said Sang. SNP, or Single Nucleotide Polymorphism, refers to the single point variations between the DNA of individuals of a species that determine traits. These lead to the existence of different versions of some genes, called alleles, and in some cases these variants arise in an individual through mutations in a single nucleotide. It is now possible to pinpoint mutations across the whole genome quickly and study how the associated genes interact. "This information can be used to investigate disease in these species but also in many cases can be useful models for similar human genetic diseases," said Sang. The conference showed how fundamental breakthroughs can be exploited in tackling disease. One of the most exciting discoveries of recent years is the fact that rods and cones are not the only light receptors in the eye, overturning the long established view. There is also a receptor, called phototropin, that recognises blue light at much lower levels, even operating in some people who are otherwise blind, playing an important role in setting the circadian clock. At the conference, one of the world's leading specialists in chronobiology (study of biological rhythms) Russell Foster, explained how mouse models were being used to study this newly discovered blue light receptor. "This has been analysed in mice and he is using the knowledge gained to interact with ophthalmologists (eye disease specialists) and patients," said Sang. Genes determine individual traits not just through their variations, or alleles, but also through differing levels of expression. Another important field of research discussed at the conference concerned the important role of microRNAs in controlling gene expression. RNAs are normally the intermediate molecules between DNA and their products, proteins, in gene expression. However microRNA is a type of RNA that instead of being involved in protein production, feeds back into the DNA coding process to regulate the expression of other genes. Mutations in the genes coding for the microRNA itself can therefore effect the expression of other genes, with some subtle and occasionally dramatic effects, as Sang pointed out. Given that animals inherit two copies, or alleles, of each gene, mutations are more likely to be effective when one of the copies is already silenced, as happens in the phenomenon known as genomic imprinting. Sang cited the case of sheep, where imprinting of a gene called callipyge leads to increased muscle growth in the hindquarters, which clearly can be a desirable trait in meat production. All these different strands of research could benefit from being integrated into a common framework to avoid duplication of effort and exploit relevant expertise, according to Sang. "The main value of the workshop was that it brought the more theoretical people together with experimental scientists and opportunities for synergies were identified." European Science Foundation | |||||||||||||||||||||
|
Related Biotechnology Current Events and Biotechnology News Articles Human genomics in China Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai. To commemorate this important event, which marks the beginning of the Genomics Era in China, we specially organize a series of mini-reviews for this special issue. Study Yields Clues About the Evolution of Epilepsy Two children have a seizure. One child never has another seizure. Twenty years later, the other child has a series of seizures and is diagnosed with epilepsy. A study being led by researchers at Rensselaer Polytechnic Institute is looking at what could possibly happen in the development of these two children that would lead to such extreme variations in their neurologic health. Scientists can now differentiate between healthy cells and cancer cells One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. Scientists Identify New Congenital Neutropenia Syndrome and Causative Gene Mutation A team of scientists has discovered a new syndrome associated with severe congenital neutropenia (SCN), a rare disorder in which children lack sufficient infection-fighting white cells, and identified the genetic cause of the syndrome: mutations in the gene Glucose-6-phosphatase, catalytic subunit 3 (G6PC3). Researcher invents lethal 'lint brush' to capture and kill cancer cells in the bloodstream In a new tactic in the fight against cancer, Cornell researcher Michael King has developed what he calls a lethal "lint brush" for the blood -- a tiny, implantable device that captures and kills cancer cells in the bloodstream before they spread through the body. Gene therapy effective treatment against gum disease Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults. Statin warning for pregnant women Pregnant women or those hoping to start or extend a family should avoid using the cholesterol-lowering drugs statins, say scientists. Maintaining the brain's wiring in aging and disease Researchers at the Babraham Institute near Cambridge, supported by the Alzheimer's Research Trust and the Biotechnology and Biological Sciences Research Council (BBSRC), have discovered that the brain's circuitry survives longer than previously thought in diseases of ageing such as Alzheimer's disease. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Australian first: Kangaroo genome mapped Australian researchers will today launch the world first detailed map of the kangaroo genome, completing the first phase of the kangaroo genomics project. More Biotechnology Current Events and Biotechnology News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||